Measurable residual disease status and outcome of transplant in acute myeloid leukemia in second complete remission: a study by the acute leukemia working party of the EBMT

Measurable residual disease (MRD) prior to hematopoietic cell transplant (HCT) for acute myeloid leukemia (AML) in first complete morphological remission (CR1) is an independent predictor of outcome, but few studies address CR2. This analysis by the Acute Leukemia Working Party of the European Socie...

全面介紹

Na minha lista:
書目詳細資料
發表在:Blood Cancer J
Main Authors: Gilleece, Maria H., Shimoni, Avichai, Labopin, Myriam, Robinson, Stephen, Beelen, Dietrich, Socié, Gerard, Unal, Ali, Ganser, Arnold, Vitek, Antonin, Sengeloev, Henrik, Yakoub-Agha, Ibrahim, Tholouli, Eleni, Polge, Emmanuelle, Mohty, Mohamad, Nagler, Arnon
格式: Artigo
語言:Inglês
出版: Nature Publishing Group UK 2021
主題:
Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC8116335/
https://ncbi.nlm.nih.gov/pubmed/33980810
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41408-021-00479-3
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍